Novel studies indicate that Retatrutide , a dual agonist targeting GLP-1 and GIP pathways , appears to be the breakthrough in body reduction. Early clinical data have promising results , with https://getretatrutideaustralia.com/blog/retatrutide-weight-loss-revolution-2026